Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of Concerta XL in adult offenders with ADHD
2012-000517-37Phase 4Completed
- Sponsor
- King's College London
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of methylphenidate hydrochloride OROS in attention deficit hyperactivity disorder (ADHD), sponsored by King's College London. Primary endpoint: Recorded critical incidents. Started Oct 2012; status: completed.
02
Drugs
methylphenidate hydrochloride OROS
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2012-000517-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000517-37.